Table 3.

Prevalence of adverse events in groups with different durations of glucocorticoid treatment.

EventsNonusers, n = 68, (%)Users < 2 yrs, n = 52, (%)Users 2–5 yrs, n = 60, (%)Users > 5 yrs, n = 185, (%)
Any adverse event32.428.847.562.7
Fractures6.03.85.026.6*
Arterial hypertension10.419.230.0**36.7***
Myocardial infarction1.59.66.616.1
Diabetes mellitus13.49.614.811.9
Cataract10.45.813.316.2
Infections3009.7††
  • * p < 0.001 vs any other group;

  • ** p < 0.01 vs nonusers;

  • *** p < 0.0002 vs nonusers and users < 2 yrs;

  • p < 0.03 vs nonusers;

  • †† p < 0.005 vs any other group.